Drug injection practices among high-risk youths: The first shot of ketamine

Journal of Urban Health

Volumn 81, Issue 2, 2004, Pages 232-248

  Lankenau, Stephen E ^a   Clatts, Michael C ^b  

^a Department of Sociomedical Sciences ^*  (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

Ethnography; High risk youth; Injection drug use; Ketamine; Street economy

Indexed keywords

DIAMORPHINE; KETAMINE;

ADULT; ARTICLE; DISSOCIATIVE DISORDER; FEMALE; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ABUSE; JUVENILE; MALE; NORTH AMERICA; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; HUMANS; HYGIENE; INJECTIONS, INTRAMUSCULAR; KETAMINE; MALE; NEW YORK CITY; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; URBAN HEALTH; URBAN POPULATION;

EID: 3042631033     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jth110     Document Type: Article

References (42)

1. Community Epidemiology Working Group. Epidemiologic Trends in Drug Abuse. Volume 1: Highlights and Executive Summary. Bethesda, MD: National Institutes of Health, Division of Epidemiology and Prevention Research, National Institute of Drug Abuse; 1999.
2. Community Epidemiology Working Group. Epidemiologic Trends in Drug Abuse. Volume 1: Highlights and Executive Summary. Bethesda, MD: National Institutes of Health, Division of Epidemiology and Prevention Research, National Institute of Drug Abuse; 2000.
3. Lankenau S, Clatts M. Ketamine injection among high risk youth: preliminary findings from New York City. J Drug Issues. 2002;32:893-906.
4. Jansen KL. Ketamine: Dreams and Realities. Sarasota, FL: Multidisciplinary Association for Psychedelic Studies; 2001.
5. Agar M. Recasting the "ethno" in "epidemiology." Med Anthropol. 1997;16:391-403.
6. Clatts MC, Welle DL, Goldsamt LA. Reconceptualizing the interaction of drug and sexual risk among MSM speed users: notes toward an ethno-epidemiology. AIDS Behav. 2001;5:115-130.
7. Clatts MC, Welle DL, Goldsamt LA, Lankenau SE. An ethno-epidemiological model for the study of trends in illicit drug use: reflections on the "emergence" of crack injection. Int J Drug Policy. 2002;13:285-295.
8. Battjes RJ, Leukefeld CG, Pickens RW. Age at first injection and HIV risk among intravenous drug users. Am J Drug Alcohol Abuse. 1992;18:263-273.
9. Marrero Rodriquez CA, Robles RR, Colon HM, Freeman D, Matos T, Reyes J. HIV risk behaviors and HIV seropositivity among young injection drug users. Puerto Rico Health Sci J. 1993;12:7-12
10. Fennema JS, Van Ameijden EJ, Van Den Hoek A, Coutinho RA. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1997; 92:1457-1465.
11. Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14:717-726.
12. Crofts N, Louie R, Rosenthal D, Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction. 1996; 91:1187-1196.
13. Fuller C, Vlahov D, Arria A, Ompad DC, Garfein R., Strathdee S. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001;116:136-145.
14. Roy E, Haley N, Leclerc P, Cedras L, Boivan JF. Drug injection among street youth: the first time. Addiction. 2002;97:1003-1009.
15. Chitwood DD, Sanchez J, Comerford M., Page JB, McBride DC, Kitner KR. First injection and current risk factors for HIV among new and long-term injection drug users. AIDS Care. 2000;12:313-320.
16. Vidal-Trecan MG, Varescon-Pousson I, Boissonnas A. Injection risk behaviors at the first and at the most recent injections among drug users. Drug Alcohol Depend. 1997;66:107-109.
17. Clatts MC, Heimer R, Abdala N, et al. HIV-1 transmission in injection paraphernalia; heating drug solutions may inactivate HIV-1. J Acquir Immune Defic Syndr Retroviorol. 2000;22:194-199.
18. Lankenau S, Clatts M, Goldsamt L, Welle, DL. Crack injection practices and HIV risk: findings from New York and Bridgeport. J Drug Issues. 2004;34:319-332.
19. Rich JD, Dickinson BP, Merriman NA, Flanigan TP. Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter [letter]. Am J Gastroenterol. 1998;93:1598.
20. Rich JD, Dickinson BP, Feller A, Pugatch D, Mylonakis E. The infectious complications of anabolic-androgenic steroid injection. Int J Sports Med. 1999;20:563-566.
21. Rich JD, Dickinson BP, Carney JM, Fisher A, Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS. 1998;12:2345-2350.
22. Clatts M, Davis W. A demographic and behavioral profile of homeless youth in New York City: implications for AIDS outreach and prevention. Med Anthropol Q. 1999;13:365-374.
23. Kipke M, O'Connor S, Palmer R, MacKenzie R. Street youth in Los Angeles. Arch Pediatr-Adolesc Med. 1995;149:513-519.
24. Evans JL, Hahn JA, Page-Shafer P, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003,80:137-146.
25. Hansen G, Jensen SB, Chandresh L, Hilden T. The psychotropic effect of ketamine. J Psychoactive Drugs. 1988;20:419-425.
26. Walker AK. Intramuscular ketamine in a developing country. Anaesthesia. 1972;27:408-414.
27. Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP. Psychedelic effects of ketamine in healthy volunteers. Anesthesiology. 1998;88:82-88.
28. Curran V, Morgan C. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction. 2000;95:575-590.
29. Siegel RK. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. NIDA Res Monogr. 1978;21:119-147.
30. Reier C. Ketamine-"dissociative agent" or hallucinogen? [letter]. N Engl J Med. 1971;14:791-792.
31. Reynolds S. Rave culture: living dream or living death? In: Redhead S, ed. The Clubcultures Reader. Malden, MA: Blackwell Publishers; 1997:84-93.
32. Dotson JW, Ackerman DL, West LJ. Ketamine abuse. J Drug Issues. 1995;25:751-757.
33. Dalgarno PJ, Shewan D. Illicit use of ketamine in Scotland. J Psychoactive Drugs. 1996;28:191-199.
34. Lai S, Chen J, Celentano D, et al. Adoption of injection practices in heroin users in Guangxi Province, China. J Psychoactive Drugs. 2000;32:285-292.
35. Neaigus A, Miller M, Friedman SR, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96:847-860.
36. Friedman S, Curtis R, Neaigus A, Jose B, Des Jarlais D. Social Networks, Drug Injectors' Lives and HIV/AIDS. New York: Kluwer Academic/Plenum Publishers AIDS; 1999.
37. Gogineni A, Stein M, Friedmann P. Social relationships and intravenous drug use among methadone maintenance patients. Drug Alcohol Depend. 2001;64:47-53.
38. Kottiri B, Friedman S, Neaigus A, Curtis R, Des Jarlais D. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2002;30:95-104.
39. Lovell A. Risking risk: the influence of types of capital and social networks on the injection practices of drug users. Soc Sci Med. 2002;55:803-821.
40. Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D. Gender differences in the initiation of injection drug use among young adults. J Urban Health. 2000;77:396-414.
41. Fuller C, Vlahov D, Latkin CA, Ompad DC, Celentano DD, Strathdee S. Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. JAIDS: J Acquir Immune Defic Syndr. 2003;32:86-93.
42. Lankenau S, Clatts M. Ketamine injection initiation among high risk youth: HIV risk in a hidden population. Poster presented at: XIV International AIDS Conference; July 2002; Barcelona, Spain.